Nordhealth insider increases stake with share purchases

Karan Wallia, therapy BU chief executive and a primary insider of Nordhealth AS, made two separate purchases of class A shares in the company. The first transaction, on September 8, 2025, involved the acquisition of 121 shares for a total of NOK 4,283. This purchase consisted of one share at NOK 35.00 and 120 shares at NOK 35.40.

The second transaction occurred on September 9, 2025, where Wallia acquired an additional 1,498 shares at a price of NOK 36.00 per share, amounting to a total value of NOK 53,928. Both transactions were executed on the Oslo Børs and reported in accordance with Market Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act Section 5-12.

Nordhealth AS, headquartered in Helsinki, Finland, provides cloud-based healthcare SaaS solutions to veterinary and therapy professionals across over 13,000 clinics in more than 30 countries.